Furthermore, we found that the loss of TBK1 function resulted in reduced invasion, migration, and tumor growth, and reduced metastatic events in preclinical models of mutant KRAS PDAC, indicating that TBK1 actively contributes to pancreatic cancer progression (105). This evidence concerns the gene TBK1 and pancreatic neoplasm.